{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:47:38Z","timestamp":1793173658446,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.radonc.2024.110607","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:39:24Z","timestamp":1730464764000},"page":"110607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial"],"prefix":"10.1016","volume":"202","author":[{"given":"Tairo","family":"Kashihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Namikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiteru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110607_b0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2152\/jmi.61.254","article-title":"Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: comparison of clinical results obtained with BNCT and conventional treatment","volume":"61","author":"Kageji","year":"2014","journal-title":"J Med Invest"},{"key":"10.1016\/j.radonc.2024.110607_b0010","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijrobp.2010.09.057","article-title":"Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I\/II trial","volume":"82","author":"Kankaanranta","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110607_b0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijrobp.2007.03.039","article-title":"Boron neutron capture therapy in the treatment of locally recurred head and neck cancer","volume":"69","author":"Kankaanranta","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110607_b0020","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.apradiso.2009.03.103","article-title":"Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies","volume":"67","author":"Kato","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.radonc.2024.110607_b0025","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.apradiso.2009.03.015","article-title":"Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients","volume":"67","author":"Kawabata","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.radonc.2024.110607_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14338\/IJPT-22-00002.1","article-title":"A review of boron neutron capture therapy: its history and current challenges","volume":"9","author":"Jin","year":"2022","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2024.110607_b0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110607_b0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2019.04.033","article-title":"Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: an analysis of dose response and survival","volume":"137","author":"Koivunoro","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110607_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.apradiso.2014.04.007","article-title":"BNCT for advanced or recurrent head and neck cancer","volume":"88","author":"Aihara","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.radonc.2024.110607_b0050","article-title":"Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study","volume":"3","author":"Kawabata","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.radonc.2024.110607_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1227\/01.neu.0000279727.90650.24","article-title":"Boron neutron capture therapy for malignant tumors related to meningiomas","volume":"61","author":"Miyatake","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2024.110607_b0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0360-3016(97)00891-2","article-title":"Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the brookhaven national laboratory","volume":"40","author":"Chadha","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110607_b0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2016.02.028","article-title":"Fractionated boron neutron capture therapy in locally recurrent head and neck cancer: a prospective phase I\/II trial","volume":"95","author":"Wang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110607_b0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jrr\/rrad037","article-title":"Relative biological effectiveness for epithermal neutron beam contaminated with fast neutrons in the linear accelerator-based boron neutron capture therapy system coupled to a solid-state lithium target","volume":"64","author":"Nakamura","year":"2023","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2024.110607_b0075","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1038\/s41598-021-87627-8","article-title":"Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target","volume":"11","author":"Nakamura","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2024.110607_b0080","doi-asserted-by":"crossref","first-page":"e0225587","DOI":"10.1371\/journal.pone.0225587","article-title":"Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target","volume":"14","author":"Nakamura","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2024.110607_b0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mp.16104","article-title":"Failure modes and effects analysis study for accelerator-based boron neutron capture therapy","volume":"50","author":"Takemori","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110607_b0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1346-8138.1994.tb03310.x","article-title":"Melanogenesis investigation leading to selective melanoma neutron capture therapy and diagnosis","volume":"21","author":"Mishima","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.radonc.2024.110607_b0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","article-title":"Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound","volume":"2","author":"Mishima","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110607_b0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0749.1989.tb00196.x","article-title":"New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial","volume":"2","author":"Mishima","year":"1989","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.radonc.2024.110607_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/09553002.2014.942013","article-title":"Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines","volume":"91","author":"Rossini","year":"2015","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2024.110607_b0110","first-page":"38","article-title":"Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget\u2019s disease with curative responses","volume":"38","author":"Hiratsuka","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.radonc.2024.110607_b0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.24554","article-title":"Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis","volume":"39","author":"Shin","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2024.110607_b0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.radonc.2024.110607_b0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoto.2014.3584","article-title":"Angiosarcoma of the scalp and face: the mayo clinic experience","volume":"141","author":"Patel","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2024.110607_b0130","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41598-022-08362-2","article-title":"Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp angiosarcomas","volume":"12","author":"Kashihara","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2024.110607_b0135","doi-asserted-by":"crossref","first-page":"e13243","DOI":"10.1111\/srt.13243","article-title":"Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas","volume":"29","author":"Kashihara","year":"2023","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.radonc.2024.110607_b0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/pin.12323","article-title":"L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors","volume":"65","author":"Koshi","year":"2015","journal-title":"Pathol Int"},{"key":"10.1016\/j.radonc.2024.110607_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1667\/RADE-20-00214.1","article-title":"Enhancement of cancer cell-killing effects of boron neutron capture therapy by manipulating the expression of L-type amino acid Transporter 1","volume":"196","author":"Ohnishi","year":"2021","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2024.110607_b0150","first-page":"128","article-title":"Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: a report of two patients","volume":"18","author":"Igaki","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110607_b0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jrr\/rrad037","article-title":"Relative biological effectiveness for epithermal neutron beam contaminated with fast neutrons in the linear accelerator-based boron neutron capture therapy system coupled to a solid-state lithium target","volume":"64","author":"Nakamura","year":"2023","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2024.110607_b0160","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.apradiso.2009.03.020","article-title":"BNCT for skin melanoma in extremities: updated Argentine clinical results","volume":"67","author":"Men\u00e9ndez","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.radonc.2024.110607_b0165","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/cells10112881","article-title":"Boron neutron capture therapy (BNCT) for cutaneous malignant melanoma using 10B-p-Boronophenylalanine (BPA) with special reference to the radiobiological basis and clinical results","volume":"10","author":"Fukuda","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2024.110607_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00008390-199902000-00010","article-title":"Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma","volume":"9","author":"Fukuda","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1016\/j.radonc.2024.110607_b0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03178777","article-title":"Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor","volume":"26","author":"Fukuda","year":"2003","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2024.110607_b0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jrr\/rraa068","article-title":"Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)","volume":"61","author":"Hiratsuka","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2024.110607_b0185","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.apradiso.2011.02.013","article-title":"The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation","volume":"69","author":"Yamamoto","year":"2011","journal-title":"Appl Radiat Isot"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:30:11Z","timestamp":1734568211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024042695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"alternative-id":["S0167814024042695"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110607","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110607"}}